blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1900378

EP1900378 - Pharmaceutical compositions for the treatment of fungal infections [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  20.02.2009
Database last updated on 03.10.2024
Most recent event   Tooltip20.02.2009Application deemed to be withdrawnpublished on 25.03.2009  [2009/13]
Applicant(s)For all designated states
Novartis AG
Lichtstrasse 35
4056 Basel / CH
[N/P]
Former [2008/12]For all designated states
Novartis AG
Lichtstrasse 35
4056 Basel / CH
Inventor(s)01 / Mayer, Friederich Karl
Im Ziegelgarten 9
4104, Oberwil / CH
 [2008/12]
Representative(s)Vallet, Lucien, et al
Novartis AG
Geistiges Eigentum Konzern
Patent- und Markenabteilung CH
Postfach
CH-4002 Basel / CH
[N/P]
Former [2008/12]Vallet, Lucien, et al
Novartis AG Geistiges Eigentum Konzern Patent- und Markenabteilung CH Postfach
CH-4002 Basel / CH
Application number, filing date06119884.231.08.2006
[2008/12]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1900378
Date:19.03.2008
Language:EN
[2008/12]
Search report(s)(Supplementary) European search report - dispatched on:EP14.02.2007
ClassificationIPC:A61K45/06, A61K31/69, A61K31/137, A61P31/10
[2008/12]
CPC:
A61K31/69 (EP,KR,US); A61K31/135 (KR); A61K31/137 (EP,US);
A61K45/06 (EP,US); A61P17/00 (EP); A61P31/10 (EP);
A61P37/02 (EP); A61P37/06 (EP); A61P43/00 (EP) (-)
C-Set:
A61K31/137, A61K2300/00 (EP,US);
A61K31/69, A61K2300/00 (US,EP)
Designated contracting states(deleted) [2008/48]
Former [2008/12]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Pharmazeutische Zusammensetzungen zur Behandlung von Pilzinfektionen[2008/12]
English:Pharmaceutical compositions for the treatment of fungal infections[2008/12]
French:Compositions pharmaceutiques pour le traitment d'infections fongiques[2008/12]
Examination procedure20.09.2008Application deemed to be withdrawn, date of legal effect  [2009/13]
04.11.2008Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2009/13]
Fees paidRenewal fee
14.08.2008Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO9533754  (ZENECA LTD [GB], et al) [A] 1-7 * page 1, lines 1-4,35-40 * * page 5, lines 33-37 * * page 6, lines 5-10 * * page 7, lines 27-34 * * page 10, lines 16-19 * * page 11, lines 5-16 * * Ex. 64 on pages 22-23;; example 1 *;
 [Y]WO2005013892  (ANACOR PHARMACEUTICALS INC [US], et al) [Y] 1-7 * page 5, line 10 - page 7, line 22 * * page 19, line 16 - page 20, line END * * page 26, line 21 - page 31, line 14 * * examples 11-39 *;
 [A]WO2005021483  (NOVARTIS AG [CH], et al) [A] 1-7* page 1 *;
 [Y]WO2006089067  (ANACOR PHARMACEUTICALS INC [US], et al) [Y] 1-7 * paragraphs [0002] , [0018] , [0001] - [0030] - [0071] - [0078] - [0103] , [0110] - [0116] - [0135] , [0144] - [0147] - [0256] , [0257]; examples 16-20 *;
 [Y]  - BAKER STEPHEN J ET AL, "Discovery of a new boron-containing antifungal agent, 5-fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole (AN2690), for the potential treatment of onychomycosis", JOURNAL OF MEDICINAL CHEMISTRY, (200607), vol. 49, no. 15, ISSN 0022-2623, pages 4447 - 4450, XP002416532 [Y] 1-7 * the whole document *

DOI:   http://dx.doi.org/10.1021/jm0603724
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.